Partillion Bioscience

About:

Partillion Bioscience is an early-stage life science company developing a functional single-cell analysis platform.

Website: https://www.partillion.com

Top Investors: National Science Foundation, Paladin Capital Group, National Institutes of Health, +ND Capital, Vertical Venture Partners

Description:

Partillion Bioscience is an early-stage life science company developing a functional single-cell analysis platform to analyze and sort single cells based on secreted proteins. The platform allows the rapid compartmentalization and analysis of millions of single cells to probe biological functions.

Total Funding Amount:

$6.07M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Los Angeles, California, United States

Founded Date:

2020-04-03

Founders:

Dino Di Carlo, Joe de Rutte

Number of Employees:

11-50

Last Funding Date:

2023-09-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai